HEMOSTASIS COAGULATION ROUTINE REAGENTS ANTICOAGULANT MONITORING DOAC RIVAROXABAN
TECHNOVIEW® Rivaroxaban Cont Medium
Medium control plasmas for the rivaroxaban assay.
TECHNOVIEW® Rivaroxaban Control Medium quality control plasmas are titrated to approximately 150 ng / mL, optimized for anti-FXa methods.
Informations
Rivaroxaban is a highly selective direct inhibitor of FXa.
This inhibition interrupts the intrinsic pathway of the blood coagulation cascade, inhibiting the formation of thrombin and the development of thrombus.
It does not inhibit thrombin and has no effect on platelets.
Documentation
Download the product sheetPrice list, safety data sheets and notices are accessible to our registered customers.
Lyophilized plasmas
References
| 4-5090173 | Vial | 5 x 1.0 mL |
